Eye of Truth
Lobbyist Report for Greater New York Hospital Association

Greater New York Hospital Association

555 WEST 57TH STREET 15th Floor NEW YORK, NY 10019

USA

Lobbying on the following issues:

HEALTH ISSUES TAXATION/INTERNAL REVENUE CODE MEDICARE/MEDICAID PHARMACY BUDGET/APPROPRIATIONS

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network. Discuss the issue of surprise medical bills with Congressional staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with Congressional staff. Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with Congressional staff. Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with Congressional staff. Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch. Discuss 405(d) Educational Programming with the HHS Office of Chief Information Officer. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

-

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

-

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Educate Congressional staff and lawmakers on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

-

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss potential legislation to address drug shortages with Congressional staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

-

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
RICH, DAVID C
COOPER, JONATHAN
ALFREDO, LAURA
KHARE, PUJA
SHURE, KATHLEEN
RASKE, KENNETH E
RYAN, LORRAINE
HELLER, KAREN SMOLER
SUMER-KING, ZEYNEP
Warshaw, Seth Dean

Foreign Entities:

Foreign Entity Name:
BHP Billiton Canada Inc.
Country :
CANADA
Contribution :
$0



Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE PHARMACY MEDICARE/MEDICAID HEALTH ISSUES BUDGET/APPROPRIATIONS

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

-

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support).

-

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act. Support a delay of the Medicaid DSH cuts. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

-

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss potential surprise billing legislation with Congressional staff and members. Support a delay of the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act.

-

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
HELLER, KAREN SMOLER
RASKE, KENNETH E
RICH, DAVID C
COOPER, JONATHAN
ALFREDO, LAURA
Warshaw, Seth Dean
RYAN, LORRAINE
SUMER-KING, ZEYNEP

Foreign Entities:

Foreign Entity Name:
Societe Generale Corporate & Investment Banking
Country :
PANAMA
Contribution :
$4,000



Lobbying on the following issues:

TAXATION/INTERNAL REVENUE CODE BUDGET/APPROPRIATIONS PHARMACY HEALTH ISSUES MEDICARE/MEDICAID

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

-

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

-

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss legislation to address drug shortages with Congressional staff and members, the MEDS Act (S. 2373) (support), advocate for its inclusion in the CARES Act (H.R. 748). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff.

-

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts.

-

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
SUMER-KING, ZEYNEP
KHARE, PUJA
SHURE, KATHLEEN
RASKE, KENNETH E
ALFREDO, LAURA
COOPER, JONATHAN
RICH, DAVID C
RYAN, LORRAINE
Warshaw, Seth Dean
HELLER, KAREN SMOLER



Lobbying on the following issues:

PHARMACY BUDGET/APPROPRIATIONS HEALTH ISSUES MEDICARE/MEDICAID TAXATION/INTERNAL REVENUE CODE

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with congressional staff. Discuss potential legislation to address drug shortages with congressional staff.

-

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

-

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Educate congressional staff on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector. Discuss CMSs FY 2020 IPPS proposed rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff and HHS. Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network. Discuss the issue of surprise medical bills with congressional staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with congressional staff. Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with congressional staff. Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with congressional staff. Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch.

-

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Educate congressional staff on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS proposed rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

-

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
HELLER, KAREN SMOLER
RASKE, KENNETH E
RICH, DAVID C
COOPER, JONATHAN
ALFREDO, LAURA
Warshaw, Seth Dean
RYAN, LORRAINE
SUMER-KING, ZEYNEP
KHARE, PUJA



Lobbying on the following issues:

MEDICARE/MEDICAID BUDGET/APPROPRIATIONS PHARMACY HEALTH ISSUES TAXATION/INTERNAL REVENUE CODE

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Educate Congressional staff and lawmakers on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), other issues related to 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS and the White House. Discuss issues related to Medicare Hospital Provider Agreements with staff from CMS. Discuss the MedPAC Review of Medicare IME payments with the MedPAC Commissioner (SSA 1186(d)).

-

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

-

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss legislation to address drug shortages with Congressional staff and members, the MEDS Act (S. 2373) (support). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

-

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), other issues related to 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network. Discuss the issue of surprise medical bills with Congressional staff and the Congressional Budget Office. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with Congressional staff. Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with Congressional staff. Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with Congressional staff. Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch. Discuss 405(d) Educational Programming with the HHS Office of Chief Information Officer. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss the MedPAC Review of Medicare IME payments with the MedPAC Commissioner (SSA 1186(d)). Discuss issues related to telehealth and HIT with Congressional staff, including the CONNECT for Health Act (S. 2741). Discuss issues related to telehealth and HIT with staff from CMS and the White House. Discuss issues related to Medicare Hospital Provider Agreements with staff from CMS.

-

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
ALFREDO, LAURA
RASKE, KENNETH E
Warshaw, Seth Dean
COOPER, JONATHAN
SHURE, KATHLEEN
SUMER-KING, ZEYNEP
RYAN, LORRAINE
KHARE, PUJA
HELLER, KAREN SMOLER
RICH, DAVID C

Foreign Entities:

Foreign Entity Name:
MIH e-commerce Holdings B.V.
Country :
NETHERLANDS
Contribution :
$0



Lobbying on the following issues:

IMMIGRATION BUDGET/APPROPRIATIONS DISASTER PLANNING/EMERGENCIES HEALTH ISSUES PHARMACY MEDICARE/MEDICAID INSURANCE TAXATION/INTERNAL REVENUE CODE

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program. Acted as a fact witness and amicus in legal challenges to the Trump Administrations executive order (Protecting the Nation for Foreign Terrorists Entry into the United States). Sent a comment letter to the Department of Homeland Security urging the withdrawal of its public charge proposed rule, "Inadmissibility on Public Charge Grounds." (Oppose)

-

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Oppose President Trumps FY 19 budget proposal (Efficient, Effective, Accountable: An American Budget), and it funding cuts and reforms to Federal GME programs, Medicaid uncompensated care pools, hospital outpatient departments, bad debt payments, and other hospital related provisions. The Bipartisan Budget Act of 2018 (H.R. 1892) (support) and specific hospital related provisions in the legislation, including increased funding for the National Institutes of Health (NIH) (support), disaster relief funding and increased Medicaid funding for Puerto Rico and the US Virgin Islands (support), and the inclusion of the cut to Medicare payments for hospitals that discharge patients to hospice care (oppose). Oppose House Republicans FY 2019 budget proposal (A Brighter American Future), and its funding cuts and reforms to Medicaid and Medicare, proposed reforms to federal GME programs, and efforts to repeal the Affordable Care Act (ACA). Support for provisions related to medical malpractice reform. Oppose the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157). Support the inclusion of language to reverse CMSs site-neutral cut in FY 2019 appropriations bills.

-

Discussed post-hurricane disaster response by the group purchasing industry, and related efforts to bring needed supplies and drugs to providers in Puerto Rico.

-

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller-Johnson bill, and the Trump Administration's FY 2019 budget proposal. Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Advocated for individual marketplace stabilization measures, including the funding of ACA cost sharing reduction payments in standalone legislation and in FY 2018 funding legislation. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), the Medicaid Graduate Medical Education Transparency Act (oppose), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA), The Overdose Prevention and Patient Safety Act (support) (H.R. 6082), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the SUPPORT for Patients and Communities Act (support) (H.R. 6). Support the Opioid Crisis Response Act of 2018 (support) (S. 2680). Lobby HHS, HRSA, OPTN and UNOS on liver allocation reforms. Support liver allocation reforms, including the Fairness in Liver Allocation Act (support) (H.R. 6517). Oppose legislation to amend the National Organ Transplant Act, the National Organ Transplant Act Amendments of 2018 (oppose) (H.R. 6458), and the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157). Oppose the FY 2020-2025 Medicaid DSH cuts, and support proposals that would delay or repeal the scheduled cuts. Support proposals that would increase funding levels for programs related to hospital infrastructure, access to capital, workforce issues, health information technology, and telehealth. Support legislative proposals to reverse the site-neutral provisions in the CMS OPPS final rule for 2019. Oppose 340b and site-neutral provisions in the CMS OPPS proposed and final rules for 2019. Raise awareness about surprise billing laws on both the federal and state levels.

-

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline and local anesthetic shortages. Oppose legislation that would harm the 340B Drug Discount Program for safety net hospitals and support legislation to prevents the implementation of the cuts in CMS Final 2017 OPPS Rule (CMS-2017-0091), the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support). Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars. Supported legislation to increase competition in the drug marketplace and prevent REMS abuses, the CREATES Act (S. 974/H.R.2214) (support). Raise awareness about generic injectable opioid shortages, urge engagement by the Food & Drug Administration Office of Drug Shortages and approval by the Drug Enforcement Agency of CII quota requests to increase production of injectable opioid products in short supply. Submitted comments to DEA urging the revision of its quota allocation process to recognize the unique institutional needs for injectable opioids. Submitted comments to DEA opposing proposed aggregate quota reductions for CY 2018 Schedule II controlled substances.

-

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose). Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool. Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal. Provide comments to CMS addressing payments to off-campus hospital outpatient departments. Support legislation to reverse the cuts to the 340B Drug Discount Program in CMS Final 2017 OPPS Rule, the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support) Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes. Oppose legislation that would harm Medicaid GME programs including the Medicaid Graduate Medical Education Transparency Act (oppose). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Oppose the FY 2020-2025 Medicaid DSH cuts, and support proposals that would delay or repeal the scheduled cuts. Support legislative proposals to reverse the site-neutral provisions in the CMS OPPS final rule for 2019. Oppose 340b and site-neutral provisions in the CMS OPPS proposed and final rules for 2019. Sent comment letter to HHS regarding its OPPS proposed rule for CY 2019. The letter addressed issues related to site-neutral policies, 340B, WAC-based payments, packaging for non-opioid pain treatments, and changes to the IPO list, among other topics.

-

The Childrens Health Insurance Program, including the reauthorization of the program in the January 2018 continuing resolution to fund the Federal government (support) (H.R. 195) and the extension of the program in the Bipartisan Budget Act of 2018 (support) (H.R. 1892). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680).

-

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

-

Lobbyists:

PERLMAN, LEE H
JOHNSON, TIM
WYNN, ELISABETH R
WALTMAN, SUSAN C
WARDE ZACCARELLI, AISLING
HELLER, KAREN SMOLER
RASKE, KENNETH E
RICH, DAVID C
SHURE, KATHLEEN
COOPER, JONATHAN
ALFREDO, LAURA
Warshaw, Seth Dean

Foreign Entities:

Foreign Entity Name:
Next Alt S.a.r.l
Country :
LUXEMBORG
Contribution :
$0



Money Spent:

Amount Client Government Entities

$650,000

Oct 18, 2019

THIRD QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)

$640,000

Apr 19, 2019

FIRST QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)

$630,000

Apr 19, 2020

FIRST QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)

$620,000

Jul 19, 2019

SECOND QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)

$620,000

Jan 17, 2020

FOURTH QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)

$580,000

Jan 18, 2019

FOURTH QUARTER REPORT

Greater New York Hospital Association

Centers For Medicare and Medicaid Services (CMS)
Substance Abuse & Mental Health Services Administr
Health & Human Services, Dept of (HHS)
White House Office
Homeland Security, Dept of (DHS)
Drug Enforcement Administration (DEA)
Food & Drug Administration (FDA)
Environmental Protection Agency (EPA)
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
SENATE
HOUSE OF REPRESENTATIVES
Centers For Disease Control & Prevention (CDC)